pharmaphorum4d
Merck makes $3.2bn from COVID-19 drug Lagevrio in Q1
Orders for Merck & Co's oral antiviral for COVID-19 helped to swell ... but even without the drug sales would have risen 19% thanks to a strong performance from cancer immunotherapy Keytruda ...
FierceBiotech9h
Merck KGaA’s phase 3 rare tumor trial hits goal, teeing up rivalry with Daiichi and Ono
Daiichi showed the mechanism can work in TGCT years ago, publishing phase 3 data in 2018 and winning FDA approval for Turalio ...
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...
Morningstar7h
Merck KGaA's Cell-Tumor Drug Gets Positive Results in Late-Stage Trial
Merck KGaA said its cell-tumor treatment Pimicotinib met its primary endpoint in a late-stage trial. The German pharma company said Tuesday that its experimental drug showed significant improvement in ...
The Motley Fool on MSN11d
Is Merck Stock a Buy?
Understanding the investment thesis for Merck requires appreciating the importance of its blockbuster cancer drug, Keytruda, ...